Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Hypertension/High Blood Pressure Health Center

Font Size

New Combo Drug May Cut Blood Pressure

Study Shows Adding a New Drug to Diovan Boosts Its Ability to Reduce Hypertension
WebMD Health News
Reviewed by Laura J. Martin, MD

March 16, 2010 - Marrying a new blood-pressure-lowering drug to an old one results in a new drug that works better than either drug alone, a manufacturer-sponsored clinical trial suggests.

Novartis's AHU377 is a new kind of blood pressure drug called a vasopeptidase inhibitor. A previous drug in this class, Bristol-Myers Squibb's omipatrilat, showed great promise but failed because of a dangerous side effect.

AHU377 does not appear to have this side effect. But it's not a very powerful drug all by itself. However, a new study suggests that it significantly boosts the effects of Novartis's Diovan, a different kind of blood pressure drug called an angiotensin II receptor blocker.

The combination of the two types of drug creates a new molecule: an ARNI or "dual-acting angiotensin II-receptor and neprilysin inhibitor," suggest Luis Miguel Ruilope, MD, of Hospital 12 October in Madrid, Spain, and colleagues.

Ruilope and colleagues tested the new drug, code-named LCZ696, in 1,328 adults ages 18 to 75 in 18 nations. Study participants had only mild-to-moderate high blood pressure: on average, 156/100 (normal blood pressure is 120/80 or less).

Across all dosages tested, LCZ696 boosted the blood-pressure lowering effect of Diovan.

At the dosage chosen for further clinical trials, 200 milligrams, LCZ696 dropped systolic blood pressure (the top number) by 11 points and diastolic blood pressure (the bottom number) by 6.14 points. An equivalent dose of Diovan alone decreased systolic blood pressure by 5.69 points and diastolic blood pressure by 3.17 points.

By comparison:

  • Reducing your weight cuts systolic blood pressure by 5 to 20 points per 22 pounds lost.
  • Regular physical activity cuts systolic blood pressure by 4 to 9 points.
  • The low-fat, high-vegetable/fruit DASH diet cuts systolic blood pressure by 8 to 14 points.
  • Cutting back drinking to no more than two drinks a day for men and one drink a day for women cuts systolic blood pressure by 2 to 4 points.

Novartis participated in the design, data collection, data interpretation, and writing of the Ruilope study.

The study findings appear in the March 16 online edition of The Lancet.

Today on WebMD

blood pressure
Symptoms, causes, and more.
Learn the causes.
Compressed heart
5 habits to change.
Mature man floating in pool, goggles on head
Exercises that help.
heart healthy living
Erectile Dysfunction Slideshow
Bernstein Hypertension Affects Cardiac Risk
Compressed heart
Heart Disease Overview Slideshow
thumbnail for lowering choloesterol slideshow
Heart Foods Slideshow
Low Blood Pressure

WebMD Special Sections